Clinical Trial Update: R01.Aim 2.Study 1: IsoReach [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 early trial named IsoReach (R01.Aim 2.Study 1) is currently recruiting for stroke, sponsored by Shirley Ryan AbilityLab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• IsoReach

Snippet

Sponsor: Shirley Ryan AbilityLab | Conditions: Stroke | EARLY_Phase 1 | Status: RECRUITING